Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease

Vitalii Poberezhets (Vinnytsia, Ukraine), Vitalii Poberezhets, Yuriy Mostovoy, Hanna Demchuk

Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Session: COPD: exacerbations, gas exchange and associated dysfunction
Session type: Thematic Poster Session
Number: 662
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vitalii Poberezhets (Vinnytsia, Ukraine), Vitalii Poberezhets, Yuriy Mostovoy, Hanna Demchuk. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease. Eur Respir J 2015; 46: Suppl. 59, 662

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009


Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 280-285
Year: 2003



Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006

Handgrip strength reflects excersice capacity and systemic inflammation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


Carnitine deficiency in chronic obstructive pulmonary disease patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Peripheral muscle atrophy in patients with cronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002

Multidimensional disease severity and peripheral muscle endurance and fatigue in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Assessment of functional status
Year: 2009


Coronary calcium and epicardial adipose tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013


Distribution of leg muscle weakness in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008



The prevalence of quadriceps weakness in COPD and the relationship with disease severity
Source: Eur Respir J 2010; 36: 81-88
Year: 2010



Respiratory muscle endurance in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 726s
Year: 2006

Compartments distribution of body composition in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Limitation to muscular activity in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 6-7
Year: 2004


Relevance of respiratory muscle strength in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Influence of inspiratory muscle weakness in exercise capacity of patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016


New modalities of nutritional aspects of pulmonary disease in the elderly
Source: Eur Respir Mon; 2009: 43: 240–255
Year: 2009

Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012